Ethic Inc. Charles River Laboratories International, Inc. Transaction History

Ethic Inc.

$5.89 Billion
Q3 2025

A detailed history of Ethic Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ethic Inc. holds 5,348 shares of CRL stock, worth $897,447. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,348

Previous 7,420 27.92%

Holding current value

$897,447

Previous $1.13 Million 25.69%

% of portfolio

0.01%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 17, 2025	SELL	$145.57 - $178.99 $301,621 - $370,867	-2,072 Reduced 27.92%	5,348 $836,000
Q2 2025 Jul 30, 2025	BUY	$99.75 - $151.89 $382,641 - $582,650	3,836 Added 107.03%	7,420 $1.13 Million
Q1 2025 May 13, 2025	BUY	$150.52 - $190.14 $539,463 - $681,461	3,584 New	3,584 $539,000
Q3 2024 Nov 13, 2024	SELL	$187.96 - $245.29 $19,735 - $25,755	-105 Reduced 9.92%	953 $187,000
Q2 2024 Aug 13, 2024	BUY	$206.39 - $268.73 $21,670 - $28,216	105 Added 11.02%	1,058 $218,000

Q1 2024 May 13, 2024	BUY	$203.52 - $273.43 $193,954 - $260,578	953 New	953 $258,000
Q2 2022 Aug 10, 2022	SELL	$204.13 - $302.4 $198,822 - $294,537	-974 Reduced 26.3%	2,730 $584,000
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $512,553 - $726,392	2,006 Added 118.14%	3,704 $1.05 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $28,813 - $36,791	-82 Reduced 4.61%	1,698 $640,000
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $70,428 - $86,618	-189 Reduced 9.6%	1,780 $735,000
Q2 2021 Aug 10, 2021	BUY	$294.17 - $371.65 $241,513 - $305,124	821 Added 71.52%	1,969 $728,000
Q1 2021 May 13, 2021	BUY	$249.67 - $299.48 $286,621 - $343,803	1,148 New	1,148 $333,000

Others Institutions Holding CRL

# of Institutions

642

Shares Held

51.6M

Call Options Held

194K

Put Options Held

174K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.54B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account